Jack A Ragheb Selected Research

Infections

11/2013	The serological evidence in humans supports a negligible risk of zoonotic infection from porcine circovirus type 2.
9/2008	High-dose humanized anti-IL-2 receptor alpha antibody (daclizumab) for the treatment of active, non-infectious uveitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jack A Ragheb Research Topics

Disease

3	Autoimmune Diseases (Autoimmune Disease) 06/2007 - 09/2002
2	Infections 11/2013 - 09/2008
1	Anaphylaxis (Anaphylactic Shock) 03/2016
1	Anemia 01/2015
1	Pure Red-Cell Aplasia 01/2015
1	Cystic Fibrosis (Mucoviscidosis) 11/2013
1	B-Cell Lymphoma (Lymphoma, B Cell) 02/2011
1	Inflammation (Inflammations) 09/2008
1	Uveitis 09/2008
1	Panuveitis 09/2008
1	Posterior Uveitis 09/2008
1	Multifocal Choroiditis 03/2007
1	Choroidal Neovascularization 03/2007

Drug/Important Bio-Agent (IBA)

2	InterferonsIBA 01/2015 - 05/2006
2	AntibodiesIBA 11/2013 - 06/2007
2	Daclizumab (Zenapax)FDA Link 09/2008 - 06/2007
1	Pharmaceutical PreparationsIBA 03/2016
1	Interleukin-2 (IL2)IBA 01/2015
1	Proteins (Proteins, Gene)FDA Link 01/2015
1	AutoantibodiesIBA 01/2015
1	Erythropoietin FDA Link 01/2015
1	HLA-DR Antigens (HLA-DR)IBA 01/2015
1	LuciferasesIBA 11/2013
1	AntigensIBA 11/2013
1	Recombinant ProteinsIBA 11/2013
1	CD40 Ligand (CD40L)IBA 02/2011
1	Retinaldehyde (Retinal)IBA 09/2008
1	Fluorescein (Funduscein)FDA LinkGeneric 09/2008
1	Sirolimus (Rapamycin)FDA Link 03/2007
1	CytokinesIBA 05/2006
1	InterleukinsIBA 05/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2006
1	Interleukin-17 (Interleukin 17)IBA 05/2006

Therapy/Procedure

2	Transplantation 11/2013 - 09/2002
2	Therapeutics 09/2008 - 09/2002